Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes

Abstract : Background: Relapse infections resulting from the activation hypnozoites produced by Plasmodium vivax and Plasmodium ovale represent an important obstacle to the successful control of these species. A single licensed drug, primaquine is available to eliminate these liver dormant forms. To date, investigations of vivax relapse infections have been few in number. Results: Genotyping, based on polymorphic regions of two genes (Pvmsp1F3 and Pvcsp) and four microsatellite markers (MS3.27, MS3.502, MS6 and MS8), of 12 paired admission and relapse samples from P. vivax-infected patients were treated with primaquine, revealed that in eight of the parasite populations in the admission and relapse samples were homologous, and heterologous in the remaining four patients. The patients’ CYP2D6 genotypes did not suggest that any were poor metabolisers of primaquine. Parasitaemia tended to be higher in the heterologous as compared to the homologous relapse episodes as was the IgG3 response. For the twelve pro- and anti-inflammatory cytokine levels measured for all samples, only those of IL-6 and IL-10 tended to be higher in patients with heterologous as compared to homologous relapses in both admission and relapse episodes. Conclusions: The data from this limited number of patients with confirmed relapse episodes mirror previous observations of a significant proportion of heterologous parasites in relapses of P. vivax infections in Thailand. Failure of the primaquine treatment that the patients received is unlikely to be due to poor drug metabolism, and could indicate the presence of P. vivax populations in Thailand with poor susceptibility to 8-aminoquinolines.
Type de document :
Article dans une revue
Malaria Journal, BioMed Central, 2017, 16, pp.228. 〈10.1186/s12936-017-1877-x〉
Liste complète des métadonnées

Littérature citée [45 références]  Voir  Masquer  Télécharger

https://hal.sorbonne-universite.fr/hal-01556770
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : mercredi 5 juillet 2017 - 15:10:56
Dernière modification le : mercredi 21 mars 2018 - 18:57:52
Document(s) archivé(s) le : mardi 23 janvier 2018 - 20:54:12

Fichier

s12936-017-1877-x.pdf
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

Sarunya Maneerattanasak, Panita Gosi, Srivicha Krudsood, Pattamawan Chimma, Jarinee Tongshoob, et al.. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes. Malaria Journal, BioMed Central, 2017, 16, pp.228. 〈10.1186/s12936-017-1877-x〉. 〈hal-01556770〉

Partager

Métriques

Consultations de la notice

197

Téléchargements de fichiers

118